It has been reported that decreasing tau levels in Aβ-forming AD mouse models prevented the post-synaptic dysfunction (Roberson et al., 2007, 2011; Ittner et al., 2010; Bi et al., 2017). This evidence concerns the gene MAPT and Alzheimer disease.